Xeris Biopharma (XERS) Insider Trading & Ownership $6.19 -0.19 (-2.98%) Closing price 04:00 PM EasternExtended Trading$6.21 +0.02 (+0.39%) As of 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Xeris Biopharma (NASDAQ:XERS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.47%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$109.50KNumber OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$3.96M Get XERS Insider Trade Alerts Want to know when executives and insiders are buying or selling Xeris Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XERS Insider Buying and Selling by Quarter Xeris Biopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/1/2026Beth HechtInsiderSell16,667$6.23$103,835.41 4/1/2026Beth HechtInsiderSell16,667$5.99$99,835.33 3/30/2026James Aloysius BradyDirectorSell10,834$5.54$60,020.36 3/2/2026Beth HechtInsiderSell16,667$6.25$104,168.75 2/2/2026Beth HechtInsiderSell16,667$7.45$124,169.15 1/8/2026Kevin MccullochInsiderSell15,000$8.00$120,000.00 1/5/2026John Patrick Shannon JrInsiderSell24,907$7.08$176,341.56 1/2/2026Beth HechtInsiderSell16,667$7.43$123,835.81 12/19/2025John JohnsonDirectorSell135,400$7.22$977,588.00 12/12/2025Barbara-Jean A Bormann-KennedyDirectorSell15,000$7.09$106,350.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/1/2025Beth HechtInsiderSell16,667$7.01$116,835.67 11/13/2025John Patrick Shannon JrInsiderSell23,242$7.46$173,385.32 11/11/2025Beth HechtInsiderSell16,667$7.40$123,335.80 9/11/2025Marla PerskyDirectorSell15,500$7.72$119,660.00 8/28/2025Jeffrey W ShermanDirectorSell42,232$7.92$334,477.44 8/13/2025John JohnsonDirectorSell107,500$7.32$786,900.00 8/12/2025Dawn HalkuffDirectorSell42,500$7.28$309,400.00 6/13/2025Kevin MccullochInsiderBuy25,000$4.38$109,500.00 (Data available from 1/1/2013 forward) XERS Insider Trading Activity - Frequently Asked Questions Who is on Xeris Biopharma's Insider Roster? The list of insiders at Xeris Biopharma includes Barbara-Jean A Bormann-Kennedy, Beth Hecht, Dawn Halkuff, James Aloysius Brady, Jeffrey W Sherman, John Johnson, John P Schmid, John Patrick Shannon Jr, Kevin Mcculloch, Marla Persky, and Paul R Edick. Learn more on insiders at XERS. What percentage of Xeris Biopharma stock is owned by insiders? 6.47% of Xeris Biopharma stock is owned by insiders. Learn more on XERS's insider holdings. Which Xeris Biopharma insiders have been buying company stock? The following insiders have purchased XERS shares in the last 24 months: John P Schmid ($10,155.45), and Kevin Mcculloch ($109,500.00). How much insider buying is happening at Xeris Biopharma? Insiders have purchased a total of 29,285 XERS shares in the last 24 months for a total of $119,655.45 bought. Which Xeris Biopharma insiders have been selling company stock? The following insiders have sold XERS shares in the last 24 months: Barbara-Jean A Bormann-Kennedy ($106,350.00), Beth Hecht ($1,013,215.92), Dawn Halkuff ($309,400.00), James Aloysius Brady ($60,020.36), Jeffrey W Sherman ($334,477.44), John Johnson ($1,764,488.00), John Patrick Shannon Jr ($349,726.88), Kevin Mcculloch ($120,000.00), and Marla Persky ($119,660.00). How much insider selling is happening at Xeris Biopharma? Insiders have sold a total of 588,784 Xeris Biopharma shares in the last 24 months for a total of $4,177,338.60 sold. Xeris Biopharma Active InsidersKevin MccullochPresident and Chief Operating Officer1 recent tradesDawn HalkuffDirectorJohn JohnsonDirector1 recent tradesMarla PerskyDirectorJeffrey W ShermanDirectorBarbara-Jean A Bormann-KennedyDirector1 recent tradesJames Aloysius BradyDirector1 recent tradesPaul R Edick (Age 70)InsiderBeth HechtInsider6 recent tradesJohn Patrick Shannon JrInsider1 recent trades More Insider Trading Tools from MarketBeat Related Companies NewAmsterdam Pharma Insider Transactions Travere Therapeutics Insider Transactions Crinetics Pharmaceuticals Insider Transactions Catalyst Pharmaceuticals Insider Transactions Amneal Pharmaceuticals Insider Transactions Oruka Therapeutics Insider Transactions ACADIA Pharmaceuticals Insider Transactions Telix Pharmaceuticals Insider Transactions Edgewise Therapeutics Insider Transactions Organon & Co. Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Latest Articles 3 Dividend Stocks With Insiders Buying in 2026Insider Buying Says Upstart Isn’t Down for the CountInsider Trades: Okta and Abbott See Buys, Micron Insiders SellMarketBeat Week in Review – 05/04 - 05/08BlackBerry Rewrites Its Own Operating System This page (NASDAQ:XERS) was last updated on 5/22/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredOne algorithm, 17 years, nearly 2,000% total returnsA physicist in Dublin claims his AI algorithm has beaten the market for 17 consecutive years - with nearly 2,0...Porter & Company | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredSystem failure: The strongest leverage for gold…$9 trillion in U.S. debt must be refinanced in 2026 - at current rates - while the largest foreign buyers of T...Golden Portfolio | SponsoredRevealed: The Best Kept Secrets On Wall StreetTom Busby, founder of the Diversified Trading Institute, is giving away his 'Little Black Book' - a collection...DTI Trader | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xeris Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xeris Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
